Organization
Biocon Ltd.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Biocon Ltd.

... PR Newswire Mylan N.V.(NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that the European Medicines ...
... drugs. Amgen Inc.; Sandoz International GmbH; Teva Pharmaceutical Industries Ltd.; Pfizer Inc.; Biocon; Samsung Bioepis; and Mylan N.V are some of the companies focusing on ...
... Pharmaceutical company Mylan NV (NASDAQ:MYL) and Biocon Ltd. (BSE code:532523) (NSE:BIOCON) on Friday jointly announced the receipt of European ...
... Mylan N.V.(NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that the European Medicines ...
... in the insulin market are Eli Lilly And Company, Novo Nordisk A/S, Biocon Ltd., Sanofi (Aventis Pharma) Ltd., Wockhardt Ltd., Julphar Ltd., GlaxoSmithKline plc, Takeda ...
... Market Drivers/Constraints: 13.3.11 Boehringer Ingelheim 13.3.10 Dr. Reddy's Laboratories 13.3.9 Amgen 13.3.8 Biocon 13.3.7 Eli Lilly 13.3.6 Samsung Bioepis 13.3.5 Merck & Co 13.3.4 Celltrion ...
... 'Biocon has received the EU GMP certification for its Sterile Drug Product manufacturing ...
... be sent to Email: Tel: 080 2808 2808 Ms. Seema Ahuja Contact: Biocon clarifies that it retains its economic interest in this arrangement vis-A -vis ...
... Biocon Ltd, Asia's premier biopharmaceutical company, announced today that its Chairperson and Managing ...
... 'The Company confirms that Biocon has received an Establishment Inspection Report (EIR) from the USFDA for its ...
Subscribe now for full coverage on Biocon Ltd.
Start My Free Trial